BioLife Solutions, Inc. (BLFS) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
45/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinBLFS / S&P 48.01% / 15.20% |
WinBLFS / S&P 25.40% / 15.00% |
LoseBLFS / S&P -1270.00% / 50.40% |
| 2026-Q11/3 |
LoseBLFS / S&P -21.09% / -4.33% |
WinBLFS / S&P 24.94% / 11.30% |
LoseBLFS / S&P -68.18% / 27.70% |
| 2025-Q41/3 |
LoseBLFS / S&P -5.21% / 2.65% |
WinBLFS / S&P 23.71% / 9.00% |
LoseBLFS / S&P -79.55% / 13.40% |
| 2025-Q32/3 |
WinBLFS / S&P 18.43% / 8.12% |
WinBLFS / S&P 94.60% / 4.61% |
LoseBLFS / S&P -95.19% / 13.45% |
| 2025-Q21/3 |
LoseBLFS / S&P -5.69% / 10.94% |
WinBLFS / S&P 71.73% / 4.83% |
LoseBLFS / S&P -94.01% / 10.63% |
| 2025-Q11/3 |
LoseBLFS / S&P -12.02% / -4.27% |
WinBLFS / S&P 36.67% / 4.98% |
LoseBLFS / S&P -84.83% / 10.57% |
| 2024-Q41/3 |
WinBLFS / S&P 3.67% / 2.41% |
LoseBLFS / S&P -2.47% / 5.25% |
LoseBLFS / S&P -71.61% / 6.15% |
| 2024-Q31/3 |
WinBLFS / S&P 16.85% / 5.89% |
LoseBLFS / S&P -7.49% / 5.89% |
LoseBLFS / S&P -55.36% / 6.11% |
| 2024-Q21/3 |
WinBLFS / S&P 15.53% / 4.28% |
LoseBLFS / S&P -28.12% / 5.38% |
LoseBLFS / S&P -12.11% / 5.12% |
| 2024-Q11/3 |
WinBLFS / S&P 14.15% / 10.56% |
LoseBLFS / S&P -26.32% / 5.71% |
LoseBLFS / S&P -57.23% / 5.59% |
| 2023-Q41/3 |
WinBLFS / S&P 17.67% / 11.69% |
LoseBLFS / S&P 0.39% / 6.81% |
LoseBLFS / S&P BLFS unavailable / 7.78% |
| 2023-Q30/3 |
LoseBLFS / S&P -37.51% / -3.27% |
LoseBLFS / S&P -68.18% / 7.52% |
LoseBLFS / S&P BLFS unavailable / -5.03% |
| 2023-Q20/3 |
LoseBLFS / S&P 1.61% / 8.74% |
LoseBLFS / S&P -55.07% / 9.50% |
LoseBLFS / S&P BLFS unavailable / -8.57% |
| 2023-Q11/3 |
WinBLFS / S&P 19.51% / 7.50% |
LoseBLFS / S&P -43.89% / 10.77% |
LoseBLFS / S&P BLFS unavailable / -15.69% |
| 2022-Q40/3 |
LoseBLFS / S&P -20.00% / 7.56% |
LoseBLFS / S&P -36.02% / 11.88% |
LoseBLFS / S&P BLFS unavailable / -17.99% |
| 2022-Q32/3 |
WinBLFS / S&P 64.74% / -4.88% |
WinBLFS / S&P 60.29% / 13.47% |
LoseBLFS / S&P BLFS unavailable / -1.41% |
| 2022-Q21/3 |
LoseBLFS / S&P -39.24% / -16.10% |
WinBLFS / S&P 99.66% / 13.71% |
LoseBLFS / S&P BLFS unavailable / 11.04% |
| 2022-Q11/3 |
LoseBLFS / S&P -39.01% / -4.60% |
WinBLFS / S&P 162.50% / 15.97% |
LoseBLFS / S&P BLFS unavailable / 42.23% |
| 2021-Q41/3 |
LoseBLFS / S&P -11.93% / 11.03% |
WinBLFS / S&P 147.79% / 15.00% |
LoseBLFS / S&P -70.73% / 96.40% |
| 2021-Q31/3 |
LoseBLFS / S&P -4.92% / 0.58% |
WinBLFS / S&P 131.84% / 10.77% |
LoseBLFS / S&P -115.00% / 69.42% |
| 2021-Q22/3 |
WinBLFS / S&P 23.64% / 8.55% |
WinBLFS / S&P 100.25% / 6.58% |
LoseBLFS / S&P -123.81% / 51.81% |
| 2021-Q11/3 |
LoseBLFS / S&P -9.75% / 6.17% |
WinBLFS / S&P 56.30% / -1.06% |
LoseBLFS / S&P -264.71% / 7.39% |
| 2020-Q43/3 |
WinBLFS / S&P 37.84% / 12.15% |
WinBLFS / S&P 75.69% / -3.72% |
WinBLFS / S&P 60.78% / -33.42% |
| 2020-Q32/3 |
WinBLFS / S&P 77.00% / 8.93% |
WinBLFS / S&P 69.81% / -2.04% |
LoseBLFS / S&P -178.95% / -27.10% |
| 2020-Q22/3 |
WinBLFS / S&P 72.11% / 20.54% |
WinBLFS / S&P 59.27% / -0.46% |
LoseBLFS / S&P -145.65% / -27.11% |
| 2020-Q12/3 |
LoseBLFS / S&P -41.29% / -19.60% |
WinBLFS / S&P 55.61% / 3.47% |
WinBLFS / S&P 4.08% / -14.75% |
| 2019-Q41/3 |
LoseBLFS / S&P -2.71% / 9.07% |
WinBLFS / S&P 38.64% / 5.36% |
LoseBLFS / S&P -133.77% / 2.99% |
| 2019-Q32/3 |
LoseBLFS / S&P -1.89% / 1.70% |
WinBLFS / S&P 40.82% / 5.02% |
WinBLFS / S&P 1800.00% / 0.21% |
| 2019-Q21/3 |
LoseBLFS / S&P -5.25% / 4.30% |
WinBLFS / S&P 53.87% / 6.64% |
LoseBLFS / S&P -1250.00% / 8.65% |
| 2019-Q12/3 |
WinBLFS / S&P 48.71% / 13.65% |
WinBLFS / S&P 73.98% / 8.12% |
LoseBLFS / S&P -426.67% / 14.29% |
| 2018-Q41/3 |
LoseBLFS / S&P -31.26% / -13.52% |
WinBLFS / S&P 79.11% / 9.05% |
LoseBLFS / S&P BLFS unavailable / 18.23% |
| 2018-Q31/3 |
WinBLFS / S&P 53.37% / 7.71% |
LoseBLFS / S&P BLFS unavailable / 10.21% |
LoseBLFS / S&P BLFS unavailable / 19.06% |
| 2018-Q21/3 |
WinBLFS / S&P 122.42% / 3.43% |
LoseBLFS / S&P BLFS unavailable / 9.03% |
LoseBLFS / S&P BLFS unavailable / 14.46% |
| 2018-Q10/3 |
LoseBLFS / S&P -14.50% / -0.76% |
LoseBLFS / S&P BLFS unavailable / 7.68% |
LoseBLFS / S&P BLFS unavailable / 12.46% |
| 2017-Q40/3 |
LoseBLFS / S&P 5.08% / 6.64% |
LoseBLFS / S&P BLFS unavailable / 7.03% |
LoseBLFS / S&P BLFS unavailable / 13.82% |
| 2017-Q31/3 |
WinBLFS / S&P 138.91% / 4.48% |
LoseBLFS / S&P BLFS unavailable / 5.68% |
LoseBLFS / S&P BLFS unavailable / 17.57% |
| 2017-Q21/3 |
WinBLFS / S&P 14.35% / 3.09% |
LoseBLFS / S&P BLFS unavailable / 4.83% |
LoseBLFS / S&P BLFS unavailable / 17.74% |
| 2017-Q11/3 |
WinBLFS / S&P 29.81% / 6.07% |
LoseBLFS / S&P BLFS unavailable / 3.67% |
LoseBLFS / S&P BLFS unavailable / 13.32% |
| 2016-Q40/3 |
LoseBLFS / S&P -12.50% / 3.82% |
LoseBLFS / S&P BLFS unavailable / 2.09% |
LoseBLFS / S&P BLFS unavailable / 7.05% |
| 2016-Q31/3 |
WinBLFS / S&P 15.00% / 3.85% |
LoseBLFS / S&P BLFS unavailable / 0.20% |
LoseBLFS / S&P BLFS unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BLFS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 48.50% | 20.78% |
| Annualized return | 48.50% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BLFS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -38.51% | 83.14% |
| Annualized return | -9.27% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | BLFS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2196.30% | 319.30% |
| Annualized return | 36.81% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |